Forte Biosciences (FBRX) Earnings Date & Reports

A.I. Advisor
published Earnings

FBRX is expected to report earnings to fall 4.19% to -15 cents per share on August 12

Forte Biosciences FBRX Stock Earnings Reports
Q2'24
Est.
$-0.15
Q1'24
Est.
$-0.16
Q4'23
Beat
by $0.28
Q3'23
Beat
by $0.31
Q4'22
Missed
by $0.08
The last earnings report on May 13 showed earnings per share of -15 cents, meeting the estimate of -15 cents. With 6.08K shares outstanding, the current market capitalization sits at 21.14M.
View a ticker or compare two or three
FBRX
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3060 Pegasus Park Drive
Phone
+1 310 618-6994
Employees
9
Web
https://www.fortebiorx.com